Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | 75,000 | reported | 01 Jul 2025 | tx 7+400,000 |
| Jaguar Health, Inc. | 5,870 | reported | 11 Dec 2025 | tx 7+103,026−3,436 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Dec 2025 | GRANT_AWARD | Jaguar Health, Inc. | 5,870 | 0.00 USD | |
| 11 Dec 2025 | GRANT_AWARD | Jaguar Health, Inc. | 5,870 | 0.00 USD | deriv |
| 01 Jul 2025 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 08 Oct 2024 | GRANT_AWARD | Jaguar Health, Inc. | 21,000 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 29 Dec 2023 | PURCHASE | Lineage Cell Therapeutics, Inc. | 10,000 | 1.09 USD | |
| 14 Aug 2023 | GRANT_AWARD | Jaguar Health, Inc. | 68,568 | 0.00 USD | |
| 01 Jul 2023 | GRANT_AWARD | Jaguar Health, Inc. | 1,718 | 0.00 USD | |
| 01 Jul 2023 | GRANT_AWARD | Jaguar Health, Inc. | 1,718 | 0.00 USD | deriv |
| 01 Jul 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 06 Apr 2023 | GRANT_AWARD | Jaguar Health, Inc. | 1,718 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 04 May 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |